DepressionRFASDNCT05464550
Role of Self-focused Attention in Depression
A study testing Eye tracker in people with Depression, run by Centre Hospitalier Henri Laborit at 1 site in France.
Trial summary
Using a task measuring the tracking of eye movements, the aim of this study is to demonstrate that individuals suffering from depression focus their attention more on their reflection in the screen after recalling a failure (and this all the more so as their depressive symptomatology is strong) . Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Depression
- What is being tested?
- Eye tracker
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteFrance
- Study dates
- 8 Dec 2021to 16 Jun 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- patients with depressive disorders according to the Diagnostic and statistical Manual of Mental Disorders (DSM-V) criteria
- Men or women, aged 18 to 60
- patients without mental impairment
- patients without neurological impairment (epilepsy, encephalopathy, head trauma)
- patients with a sufficient command of French
- free patients, without guardianship or curators or subordination
Show all 9Show fewer
- patients benefiting from coverage by a social security scheme or benefiting from it through a third party in accordance with the French law on biomedical research
- obtaining oral non-objection by the patient after clear and honest information about the study
- Patient with normal or corrected vision without rigid contact lenses
Who cannot join
- patients with an intelligence quotient < 70
- patients aged < 18 years or > 60 years
- patients with mental impairment
- patients with neurological impairment (epilepsy, encephalopathy, head trauma)
- patients who do not speak French well enough
- patients hospitalized under duress
- patients without social security
- Patient wearing rigid contact lenses
Trial locations and contacts
1 site in 1 country.
About this study
Using a task measuring the tracking of eye movements, the aim of this study is to demonstrate that individuals suffering from depression focus their attention more on their reflection in the screen after recalling a failure (and this all the more so as their depressive symptomatology is strong) .
- Conditions
- Depression
- Being tested
- Eye tracker
- Medical subject headings
- Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Eye trackerBehavioural
Eye movements on a screen are captured with an eye tracker during a repeated measures before/after a directed autobiographical recall.
| Study group | Role | What they receive |
|---|---|---|
| Eye tracking | Experimental | Utilisation of a eye tracker on a screen. Receives: Behavioral: Eye tracker |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of time
Average percentage of time spent on the area of a reflective black computer screen after and before remembering a failure. The area of interest encompasses the reflection of the patient's face, without his attention being explicitly drawn to this area.
Measured: through study completion, an average of 10 months.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Jul 2022
- Study start8 Dec 2021
- Primary completion15 Jun 2022
- Study completion16 Jun 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for DepressionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Henri Laborit
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05464550
- Sponsor's protocol ID
- 2021-A01098-33
- Acronym
- RFASD
- Status last verified
- Sep 2026
- First submitted
- 21 Apr 2022
- Last updated
- 9 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Moneger J, Harika-Germaneau G, Jaafari N, Doolub D, Warck L, Selimbegovic L, Chatard A. Depressive self-focus bias following failure: an eye-tracking study among individuals with clinical depression. Front Psychiatry. 2024 Oct 1;15:1459831. doi: 10.3389/fpsyt.2024.1459831. eCollection 2024.
PubMed 39411400
Study at a glance
From the registry record, last updated by the sponsor on 9 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Role of Self-focused Attention in Depression
- ClinicalTrials.gov ID
- NCT05464550
- Acronym / sponsor ID
- RFASD / 2021-A01098-33
- Conditions
- Depression
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Centre Hospitalier Henri LaboritUniversity, hospital or other
- Study start
- 8 Dec 2021 (actual)
- Primary completion
- 15 Jun 2022 (actual)
- Study completion
- 16 Jun 2022 (actual)
- First posted
- 19 Jul 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Using a task measuring the tracking of eye movements, the aim of this study is to demonstrate that individuals suffering from depression focus their attention more on their reflection in the screen after recalling a failure (and this all the more so as their depressive symptomatology is strong) .
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Eye tracking | Experimental | Behavioral: Eye trackerUtilisation of a eye tracker on a screen. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (9 listed)
- patients with depressive disorders according to the Diagnostic and statistical Manual of Mental Disorders (DSM-V) criteria
- Men or women, aged 18 to 60
- patients without mental impairment
- patients without neurological impairment (epilepsy, encephalopathy, head trauma)
- patients with a sufficient command of French
Key exclusion criteria (8 listed)
- patients with an intelligence quotient < 70
- patients aged < 18 years or > 60 years
- patients with mental impairment
- patients with neurological impairment (epilepsy, encephalopathy, head trauma)
- patients who do not speak French well enough
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Eye trackerEye movements on a screen are captured with an eye tracker during a repeated measures before/after a directed autobiographical recall. | Behavioural | Eye tracking |
Primary outcome
Percentage of time
Time frame: through study completion, an average of 10 months.
Average percentage of time spent on the area of a reflective black computer screen after and before remembering a failure. The area of interest encompasses the reflection of the patient's face, without his attention being explicitly drawn to this area.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Sep 2026.
- Results publication: PubMed 39411400Moneger J, Harika-Germaneau G, Jaafari N, Doolub D, Warck L, Selimbegovic L, Chatard A. Depressive self-focus bias following failure: an eye-tracking study among individuals with clinical depression. Front Psychiatry. 2024 Oct 1;15:1459831. doi: 10.3389/fpsyt.2024.1459831. eCollection 2024.
- Individual participant dataSharing planned: No
Related trials for Depression
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Recruiting
Cultural Adaptation of an Online Parenting Intervention to Reduce the Risk of Depression and Anxiety in Adolescents
Risk of Depression and Anxiety
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Eye tracker in people with Depression, run by Centre Hospitalier Henri Laborit at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of time (time frame: through study completion, an average of 10 months.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05464550, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2026.